abstract |
A novel type of pyrrolopyrazole derivatives shown in general formula (I), a preparation method therefor and use thereof or a pharmaceutical composition containing same as a therapeutic agent, particularly as a gastric acid secretion inhibitor and a potassium-competitive acid blocker (P-CABs) in biomedicine. |